• Home
  • Study Details
Coming Soon

Efficacy of Tezepelumab in Peanut Oral Immunotherapy (Zenith)

ZENITH is a clinical study testing whether peanut oral immunotherapy in combination with an experimental medication will help people allergic to peanut become less sensitive to peanuts and lower the risk of life threatening allergic reactions.

Age & Gender

  • 12 years ~ 55 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide), South Carolina, Virginia

Additional Study Information

Principal Investigator

Edwin Kim
Pediatrics - Allergy Immunology and Rheumatology

Study Type

Clinical or Medical
Interventional

Study Topics

Allergy

IRB Number

25-0630

ClinicalTrials.gov

NCT07015996

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research